Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | KCTD5 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → KCTD5 |
| (<<) AIFM1 → KCTD5 |
| (<<) ALDOA → KCTD5 |
| (<<) ATP2C1 → KCTD5 |
| (<<) CD3EAP → KCTD5 |
| (<<) GNA12 → KCTD5 |
| (<<) HSP90AA1 → KCTD5 |
| (<<) JUND → KCTD5 |
| (<<) KRT1 → KCTD5 |
| (<<) MAP2K2 → KCTD5 |
| (<<) MAP2K3 → KCTD5 |
| (<<) PODXL → KCTD5 |
| (<<) ROBO3 → KCTD5 |
| (<<) SMARCC2 → KCTD5 |
| (<<) STEAP1 → KCTD5 |
| (<<) TUBA1B → KCTD5 |
| (<<) TUBA1C → KCTD5 |
| (<<) TXNIP → KCTD5 |
| Downstream (Children) |
|---|
| KCTD5 → ACAT2 (>>) |
| KCTD5 → ARHGAP10 (>>) |
| KCTD5 → ASB1 (>>) |
| KCTD5 → ASTN2 (>>) |
| KCTD5 → CBS (>>) |
| KCTD5 → CCNE1 (>>) |
| KCTD5 → CFL1 (>>) |
| KCTD5 → DYRK1A (>>) |
| KCTD5 → EIF2C2 (>>) |
| KCTD5 → FADS2 (>>) |
| KCTD5 → GLI3 (>>) |
| KCTD5 → GRB7 (>>) |
| KCTD5 → GSTK1 (>>) |
| KCTD5 → HDAC3 (>>) |
| KCTD5 → HSPA9 (>>) |
| KCTD5 → ITGA2 (>>) |
| KCTD5 → LAMB2 (>>) |
| KCTD5 → MAP3K3 (>>) |
| KCTD5 → NOL9 (>>) |
| KCTD5 → PAK4 (>>) |
| KCTD5 → PGF (>>) |
| KCTD5 → PHGDH (>>) |
| KCTD5 → PLA2G3 (>>) |
| KCTD5 → PRKX (>>) |
| KCTD5 → RPL36 (>>) |
| KCTD5 → SLC25A37 (>>) |
| KCTD5 → STX12 (>>) |
| KCTD5 → STYK1 (>>) |
| KCTD5 → TK1 (>>) |
| KCTD5 → TMEM158 (>>) |
| KCTD5 → TMEM39B (>>) |
| KCTD5 → TNFRSF1A (>>) |
| KCTD5 → TRIB3 (>>) |
| KCTD5 → UPP1 (>>) |
| KCTD5 → ZFP36L1 (>>) |
